Ipsen’s IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market Space | DelveInsight
The European Commission has granted conditional approval for Ipsen’s IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults,…
